JP7423088B2 - パントテンアミドアナログ - Google Patents

パントテンアミドアナログ Download PDF

Info

Publication number
JP7423088B2
JP7423088B2 JP2021538231A JP2021538231A JP7423088B2 JP 7423088 B2 JP7423088 B2 JP 7423088B2 JP 2021538231 A JP2021538231 A JP 2021538231A JP 2021538231 A JP2021538231 A JP 2021538231A JP 7423088 B2 JP7423088 B2 JP 7423088B2
Authority
JP
Japan
Prior art keywords
propyl
protozoa
compound
dioxane
pantothenamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021538231A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022515549A5 (https=
JP2022515549A (ja
Inventor
スカルクウェイク、ヨセフス
ハロルド ハン ヘルムケンス、ペドロ
ヤーコブ デイスリング、クーン
ビクター ボナート、ロジャー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MMV Medicines for Malaria Venture
Original Assignee
MMV Medicines for Malaria Venture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MMV Medicines for Malaria Venture filed Critical MMV Medicines for Malaria Venture
Publication of JP2022515549A publication Critical patent/JP2022515549A/ja
Publication of JP2022515549A5 publication Critical patent/JP2022515549A5/ja
Application granted granted Critical
Publication of JP7423088B2 publication Critical patent/JP7423088B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2021538231A 2018-12-31 2019-12-30 パントテンアミドアナログ Active JP7423088B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18215980.6A EP3674288A1 (en) 2018-12-31 2018-12-31 Pantothenamide analogues
EP18215980.6 2018-12-31
PCT/EP2019/087147 WO2020141155A1 (en) 2018-12-31 2019-12-30 Pantothenamide analogues

Publications (3)

Publication Number Publication Date
JP2022515549A JP2022515549A (ja) 2022-02-18
JP2022515549A5 JP2022515549A5 (https=) 2022-12-12
JP7423088B2 true JP7423088B2 (ja) 2024-01-29

Family

ID=64949100

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021538231A Active JP7423088B2 (ja) 2018-12-31 2019-12-30 パントテンアミドアナログ

Country Status (7)

Country Link
US (2) US11572336B2 (https=)
EP (2) EP3674288A1 (https=)
JP (1) JP7423088B2 (https=)
CN (1) CN113286778B (https=)
CA (1) CA3125354C (https=)
ES (1) ES2953044T3 (https=)
WO (1) WO2020141155A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3674288A1 (en) 2018-12-31 2020-07-01 MMV Medicines for Malaria Venture Pantothenamide analogues
WO2023137529A1 (en) * 2022-01-24 2023-07-27 Australian National University Anti-parasite compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130345270A1 (en) 2010-11-12 2013-12-26 Waake Forest University Health Sciences Methods of treating cancer and other disorders
JP2017535606A (ja) 2014-11-06 2017-11-30 ラドバウド ウニヴェルシテール メディシュ セントルムＲａｄｂｏｕｄ Ｕｎｉｖｅｒｓｉｔａｉｒ Ｍｅｄｉｓｃｈ Ｃｅｎｔｒｕｍ パントテンアミド類似体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035296A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
WO2011152720A1 (en) 2010-05-31 2011-12-08 Umc St. Radboud Pantothenic acid derivatives and their use in the treatment of microbial infections
WO2017066763A1 (en) * 2015-10-15 2017-04-20 Cornell University Proteasome inhibitors and uses thereof
EP3674288A1 (en) 2018-12-31 2020-07-01 MMV Medicines for Malaria Venture Pantothenamide analogues

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130345270A1 (en) 2010-11-12 2013-12-26 Waake Forest University Health Sciences Methods of treating cancer and other disorders
JP2017535606A (ja) 2014-11-06 2017-11-30 ラドバウド ウニヴェルシテール メディシュ セントルムＲａｄｂｏｕｄ Ｕｎｉｖｅｒｓｉｔａｉｒ Ｍｅｄｉｓｃｈ Ｃｅｎｔｒｕｍ パントテンアミド類似体

Also Published As

Publication number Publication date
US20230159437A1 (en) 2023-05-25
US11834391B2 (en) 2023-12-05
BR112021011875A2 (pt) 2021-09-08
US11572336B2 (en) 2023-02-07
EP3906225A1 (en) 2021-11-10
EP3674288A1 (en) 2020-07-01
EP3906225C0 (en) 2023-07-05
ES2953044T3 (es) 2023-11-07
BR122023026497A2 (pt) 2024-01-30
CN113286778B (zh) 2023-09-22
EP3906225B1 (en) 2023-07-05
CA3125354C (en) 2025-03-11
CN113286778A (zh) 2021-08-20
WO2020141155A1 (en) 2020-07-09
JP2022515549A (ja) 2022-02-18
US20220073450A1 (en) 2022-03-10
CA3125354A1 (en) 2020-07-09

Similar Documents

Publication Publication Date Title
TW201412738A (zh) 適合作為傑納斯激酶（ｊａｎｕｓ ｋｉｎａｓｅ）抑制劑之氮雜吲哚
US11834391B2 (en) Pantothenamide analogues
US11142503B2 (en) (−)-huperzine A processes and related compositions and methods of treatment
US11098013B2 (en) Small molecule N-(α-peroxy) carbazole compounds and methods of use
WO2011152721A1 (en) Derivatives of pantothenic acid and their use for the treatment of malaria
EP3022200B1 (en) New anti-malarial agents
EP3455208B1 (en) Small molecule n-(alpha-peroxy) indole compounds and methods of use
TW202102502A (zh) 作為流感病毒複製抑制劑之稠合多環吡啶酮化合物
HK40055079A (en) Pantothenamide analogues
HK40055079B (en) Pantothenamide analogues
BR122023026497B1 (pt) Uso de um composto e método para produzir um composto
BR112021011875B1 (pt) Composto e composição farmacêutica
JP2017535606A (ja) パントテンアミド類似体
KR20030027094A (ko) 신규 에스테르 또는 아미드 유도체
CN107454901A (zh) 作为抗疟疾剂的新的取代的三唑并嘧啶

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221202

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221202

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20221202

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230417

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230606

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231004

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20231004

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20231024

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231219

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240110

R150 Certificate of patent or registration of utility model

Ref document number: 7423088

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150